Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss, net of tax	Accumulated Deficit
Balance at Dec. 31, 2022	$ 80,754	$ 32	$ 329,387	$ 10	$ (248,675)
Balance, Shares at Dec. 31, 2022		31,827,659
Exercise of common stock options	4		4
Exercise of common stock options, Shares		2,115
Issuance of common stock upon RSU vesting, shares		7,041
Unrealized loss on available-for-sale securities	(22)			(22)
Stock-based compensation	1,610		1,610
Net Income (Loss)	(16,255)				(16,255)
Balance at Mar. 31, 2023	66,091	$ 32	331,001	(12)	(264,930)
Balance, Shares at Mar. 31, 2023		31,836,815
Balance at Dec. 31, 2023	89,420	$ 57	400,685	33	(311,355)
Balance, Shares at Dec. 31, 2023		57,214,550
Exercise of common stock options	$ 3		3
Exercise of common stock options, Shares	918	918
Shares issued under ATM, net of issuance costs of $150	$ 4,850	$ 1	4,849
Shares issued under ATM, net of issuance costs, Shares		1,041,666
Exercise of pre-funded warrants	2	$ 1	1
Exercise of pre-funded warrants, Shares		1,255,500
Exercise of common stock warrants	3,808	$ 2	3,806
Exercise of common stock warrants, Shares		1,424,272
Issuance of common stock upon RSU vesting, shares		27,869
Unrealized loss on available-for-sale securities	(8)			(8)
Stock-based compensation	1,881		1,881
Net Income (Loss)	(22,452)				(22,452)
Balance at Mar. 31, 2024	$ 77,504	$ 61	$ 411,225	$ 25	$ (333,807)
Balance, Shares at Mar. 31, 2024		60,964,775